Search
for

    GlossarymRNA vaccine

    uses genetic instructions to trigger an immune response

    An mRNA vaccine, or messenger RNA vaccine, is a type of vaccine that uses a small piece of the genetic material from a virus to instruct cells in the body to produce a protein that triggers an immune response. This immune response helps the body recognize and fight the actual virus if it is encountered in the future. Unlike traditional vaccines, which often use weakened or inactivated forms of a virus, mRNA vaccines do not contain live virus particles, making them quicker and easier to produce.

    Related Terms

    Learn

    2 / 2 results

      learn Exosomes

      Microscopic delivery system that sends growth-promoting signals to hair follicles

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

    Research

    5 / 1000+ results

    Community Join

    5 / 45 results

      community Be careful ordering from Umbrella Labs.

      in Product  27 upvotes 2 months ago
      A user experienced issues with an order from Umbrella Labs, initially not receiving their product, PP405, and facing poor customer service, but eventually received the order after posting about it. Other users also reported similar problems with incomplete orders and lack of communication from the company.

      community Rosemary oil's potency as a dht blocker

      in Research/Science  65 upvotes 2 years ago
      Rosemary extract showed high inhibitory activity against DHT, similar to finasteride and dutasteride, but the conversation includes skepticism about its effectiveness in humans since the study was done on mice and rosemary oil is often considered ineffective based on personal experiences. Some suggest trying rosemary oil alongside other treatments, while others emphasize the difference between the extract used in the study and the oil.

      community When could we expect pp405 to hit the market?

      in Research/Science  30 upvotes 8 months ago
      PP405 is expected to finish Phase 2 trials in late 2025, with potential market availability around 2028-2029 if all goes well. Current treatments like finasteride and minoxidil are still popular, while new options like KX-826 and Breezula are anticipated soon.